US Patent Issued to KUMIAI CHEMICAL INDUSTRY, UNIVERSITY PUBLIC CORPORATION OSAKA on Nov. 3 for "Nucleic acid that interacts with a receptor for endocrine disrupting chemicals and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,229, issued on Nov. 3, was assigned to KUMIAI CHEMICAL INDUSTRY Co. LTD. (Tokyo) and UNIVERSITY PUBLIC CORPORATION OSAKA (Osaka, Japan).

"Nucleic acid that interacts with a receptor for endocrine disrupting chemicals and use thereof" was invented by Masahiro Ogawa (Tokyo), Sayoko Harashima (Sakai, Japan), Masanobu Kawanishi (Sakai, Japan) and Takashi Yagi (Sakai, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a nucleic acid that enables evaluation of various endocrine disrupting actions of a very small amount of endocrine disrupting chemicals with high sensitivity. Such nucleic acid comprises a total of 20 to 60 nucleoti...